Ang2 upregulation is seen primarily in EC of small cell lung cancer, hepatocellular carcinoma, neuroblastoma, gastric cancer, colon cancer, and Kaposi sarcoma, with Ang2 being associated with poor prognosis in many of these tumors [8–16]. This evidence concerns the gene ANGPT2 and small cell lung carcinoma.